EP 4093377 A1 20221130 - THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
Title (en)
THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
Title (de)
THERAPEUTISCHE VERBINDUNGEN, FORMULIERUNGEN UND VERWENDUNGEN DAVON
Title (fr)
COMPOSÉS THÉRAPEUTIQUES, FORMULATIONS ET LEURS UTILISATIONS
Publication
Application
Priority
- US 202062965738 P 20200124
- US 2021014642 W 20210122
Abstract (en)
[origin: US2021228512A1] Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation.
IPC 8 full level
A61K 9/10 (2006.01); A61K 47/10 (2017.01)
CPC (source: EP KR US)
A61K 9/0053 (2013.01 - EP US); A61K 9/1075 (2013.01 - EP KR); A61K 9/1635 (2013.01 - EP); A61K 9/4825 (2013.01 - US); A61K 9/4858 (2013.01 - EP KR US); A61K 9/4866 (2013.01 - EP US); A61K 9/4875 (2013.01 - US); A61K 9/5138 (2013.01 - EP); A61K 31/167 (2013.01 - KR); A61K 31/18 (2013.01 - EP US); A61K 47/10 (2013.01 - EP KR); A61K 47/26 (2013.01 - EP KR); A61K 47/44 (2013.01 - EP); A61P 29/00 (2017.12 - KR); A61P 35/00 (2017.12 - KR); A61P 43/00 (2017.12 - KR); C07C 311/29 (2013.01 - KR); C07B 2200/13 (2013.01 - KR); Y02A 50/30 (2017.12 - EP)
Citation (search report)
See references of WO 2021150912A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
US 11077077 B1 20210803; US 2021228512 A1 20210729; AU 2021209679 A1 20220616; BR 112022014660 A2 20220913; CA 3159181 A1 20210729; CN 115052584 A 20220913; EP 4093377 A1 20221130; JP 2023520273 A 20230517; KR 20220131947 A 20220929; MX 2022008914 A 20220816; US 11547683 B2 20230110; US 2021322347 A1 20211021; US 2023285334 A1 20230914
DOCDB simple family (application)
US 202117203639 A 20210316; AU 2021209679 A 20210122; BR 112022014660 A 20210122; CA 3159181 A 20210122; CN 202180009695 A 20210122; EP 21705384 A 20210122; JP 2022526518 A 20210122; KR 20227028270 A 20210122; MX 2022008914 A 20210122; US 202117305009 A 20210629; US 202218059270 A 20221128